Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 13/20 | 0.51 |
| ▸ | ERBB2 | P04626 | 6/20 | 0.51 |
| ▸ | STK3 | Q13188 | 6/20 | 0.50 |
| ▸ | STK4 | Q13043 | 4/20 | 0.50 |
| ▸ | BTK | Q06187 | 1/20 | 0.47 |
| ▸ | SRC | P12931 | 1/20 | 0.45 |
| ▸ | KDR | P35968 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14855119 | 0.88 | STK3 (0.57) | EGFRERBB2STK3STK4BTK | |
| SCHEMBL21568987 | 0.84 | STK3 (0.60) | EGFRERBB2STK3STK4BTK | |
| SCHEMBL21569018 | 0.84 | EGFR (0.57) | EGFRERBB2STK3STK4BTK | |
| SCHEMBL21568986 | 0.83 | EGFR (0.53) | EGFRERBB2STK3STK4BTK | |
| SCHEMBL21569029 | 0.83 | STK4 (0.61) | EGFRERBB2STK3STK4BTK | |
| SCHEMBL21568985 | 0.83 | EGFR (0.64) | EGFRERBB2STK3STK4BTK | |
| SCHEMBL14855006 | 0.82 | STK3 (0.61) | EGFRERBB2STK3STK4BTK | |
| SCHEMBL14855241 | 0.82 | STK3 (0.63) | EGFRERBB2STK3STK4BTK | |
| SCHEMBL21568982 | 0.82 | EGFR (0.55) | EGFRERBB2STK3STK4BTK | |
| SCHEMBL21568992 | 0.82 | EGFR (0.55) | EGFRERBB2STK3STK4BTK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3222620-B1 | CYANOQUINOLINE DERIVATIVES | TIANJIN HEMAY ONCOLOGY PHARMACEUTICAL CO LTD (CN) | 2019-11-20 | — | — | EP | claimed |